Metropolis Healthcare has acquired Dr. RS Patil’s Ambika Pathology Laboratory, a sole proprietorship, effective September 18, 2025. The acquisition was executed under a Business Transfer Agreement (BTA). Operations of Ambika Pathology will now be carried out under Metropolis Healthcare, expanding their service offerings.
Acquisition of Ambika Pathology
Metropolis Healthcare has announced the acquisition of Dr. RS Patil’s Ambika Pathology Laboratory (‘Ambika Pathology’), a sole proprietorship firm of Dr. Rajendra Sadashiv Patil. The acquisition became effective on September 18, 2025.
Terms of the Agreement
The acquisition was completed as per the agreed terms under the Business Transfer Agreement (‘BTA’). The company has stated that all terms and conditions, including deferred consideration, will be carried out in accordance with the BTA. With this transfer, the operations of Ambika Pathology are now under the management and operation of Metropolis Healthcare.
Source: BSE
